Tirzepatide, originally developed as a therapy for blood sugar issues, has shown remarkable effectiveness in promoting weight reduction when administered. Distinct from many previous weight loss drugs , it operates by targeting two regulators: the GLP-1 hormone and glucose-dependent insulinotropic polypeptide . This double method helps patients to